Treatment-related leukemia after taxane and platinum therapy in gynecological cancer patients (Gynecologic Oncology Trial and Investigation Consortium 011).

Manabu SakuraiToyomi SatohYuko NakamuraYuji TakeiSuzuyo TakahashiHiroyuki FujiwaraKazuto NakamuraTatsuya KanumaKeiichi FujiwaraMitsuaki Suzuki

Published in: The journal of obstetrics and gynaecology research (2021)

Patients receiving taxane/platinum therapy should undergo long-term follow-up with attention to the development of TRL, even if the gynecologic malignant cancer is in remission.

Keyphrases

clinical trial
palliative care
papillary thyroid
study protocol
bone marrow
stem cells
endometrial cancer
phase ii
metastatic breast cancer
randomized controlled trial
squamous cell
young adults
replacement therapy
open label